Fol. Biol. 2013, 59, 204-206

https://doi.org/10.14712/fb2013059050204

RHOA, SEMA3B, and CKAP2 Expression in Leukaemia of Different Types: the Results of a Pilot Experiment

Eugene A. Klimov1, N. L. Selivanova2, G. I. Razumnova2, O. I. Rudko1, P. K. Golovatenko-Abramov2

1Faculty of Biology, Lomonosov Moscow State University, Moscow, Russia
2Vavilov Institute of General Genetics, Russian Academy of Sciences, Moscow, Russia

Received May 2013
Accepted May 2013

References

1. Aznar, S., Fernández-Valerón, P., Espina, C., Lacal, J. C. (2004) Rho GTPases: potential candidates for anticancer therapy. Cancer Lett. 206, 181-191. <https://doi.org/10.1016/j.canlet.2003.08.035>
2. Bae, C. D., Sung, Y. S., Jeon, S. M., Suh, Y., Yang, H. K., Kim, Y. I., Park, K. H., Choi, J., Ahn, G., Park, J. (2003) Upregulation of cytoskeletal-associated protein 2 in primary human gastric adenocarcinomas. J. Cancer Res. Clin. Oncol. 129, 621-630. <https://doi.org/10.1007/s00432-003-0484-0>
3. Braga, E. A, Loginov, V. I., Klimov, E. A., Kilosanidze, G., Khodyrev, D. S., Kaganova, N. L., Kazybskaia, T. P., Ermilova, V. D., Gar’kavtseva, R. F., Pronina, I. V., Rud’ko, O. I., Zabarskiĭ, E. R., Sulimova, G. E., Kiselev, L. L. (2006) Activation of RHOA gene transcription in epithelial tumors may be caused by gene amplification and/or demethylation of its promotor region. Mol. Biol. (Mosk.) 40, 865-877. <https://doi.org/10.1134/S002689330605013X>
4. Castro-Rivera, E., Ran, S., Thorpe, P., Minna, J. D. (2004) Semaphorin 3B (SEMA3B) induces apoptosis in lung and breast cancer, whereas VEGF165 antagonizes this effect. Proc. Natl. Acad. Sci. USA 101, 11432-11437. <https://doi.org/10.1073/pnas.0403969101>
5. Etienne-Manneville, S., Hall, A. (2002) Rho GTPases in cell biology. Nature 420, 629-635. <https://doi.org/10.1038/nature01148>
6. Jin, Y., Murakumo Y., Ueno, K., Hashimoto, M., Watanabe, T., Shimoyama, Y., Ichihara, M., Takahashi, M. (2004) Identification of a mouse cytoskeleton-associated protein, CKAP2, with microtubule-stabilizing properties. Cancer Sci. 95, 815-821. <https://doi.org/10.1111/j.1349-7006.2004.tb02187.x>
7. Kamai, T., Kawakami, S., Koga, F., Arai, G., Takagi, K., Arai, K., Tsujii, T., Yoshida, K. I. (2003) RhoA is associated with invasion and lymph node metastasis in upper urinary tract cancer. BJU Int. 91, 234-238. <https://doi.org/10.1046/j.1464-410X.2003.03063.x>
8. Lessey, E. C., Guilluy, C., Burridge, K. (2012) From mechanical force to RhoA activation. Biochemistry 51, 7420-7432. <https://doi.org/10.1021/bi300758e>
9. Liu, N., Bi, F., Pan, Y., Sun, L., Xue, Y., Shi, Y., Yao, X., Zheng, Y., Fan, D. (2004) Reversal of the malignant phenotype of gastric cancer cells by inhibition of RhoA expression and activity. Clin. Cancer Res. 10, 6239-6247. <https://doi.org/10.1158/1078-0432.CCR-04-0242>
10. Maouche-Chrétien, L., Deleu, N., Badoual, C., Fraissignes, P., Berger, R., Gaulard, P., Roméo, P. H., Leroy-Viard, K. (1998) Identification of a novel cDNA, encoding a cytoskeletal associated protein, differentially expressed in diffuse large B cell lymphomas. Oncogene 17, 1245-1251. <https://doi.org/10.1038/sj.onc.1202048>
11. Pan, Y., Bi, F., Liu, N., Xue, Y., Yao, X., Zheng, Y., Fan, D. (2004) Expression of seven main Rho family members in gastric carcinoma. Biochem. Biophys. Res. Commun. 315, 686-691. <https://doi.org/10.1016/j.bbrc.2004.01.108>
12. Parri, M., Chiarugi, P. (2010) Rac and Rho GTPases in cancer cell motility control. Cell Commun. Signal. 8, 23. <https://doi.org/10.1186/1478-811X-8-23>
13. Pronina, I. V., Loginov, V. I., Prasolov, V. S., Klimov, E. A., Khodyrev, D. S., Kazubskaia, T. P., Gar’kavtseva, R. F., Sulimova, G. E., Braga, E. A. (2009) Alteration of SEMA3B gene expression levels in epithelial tumors. Mol. Biol. (Mosk.) 43, 439-445. <https://doi.org/10.1134/S002689330903008X>
14. Rakhmanaliev, E. R., Klimov, E. A., Kompaniĭtsev, A. A., Sulimova, G. E. (2002) The structure of the human oncogenesis-associated CKAP2 (LB1) gene. Mol. Biol. (Mosk.) 36, 985-989. <https://doi.org/10.1023/A:1021625724411>
15. Roche, J., Drabkin, H. A. (2001) The role of semaphorins in lung cancer. Clin. Lung Cancer 3, 145-150. <https://doi.org/10.3816/CLC.2001.n.026>
16. Tsuchihara, K., Lapin, V., Bakal, C., Okada, H., Brown, L., Hirota-Tsuchihara, M., Zaugg, K., Ho, A., Itie-Youten, A., Harris-Brandts, M., Rottapel, R., Richardson, C. D., Benchimol, S., Mak, T. W. (2005) Ckap2 regulates aneuploidy, cell cycling, and cell death in a p53-dependent manner. Cancer Res. 65, 6685-6691. <https://doi.org/10.1158/0008-5472.CAN-04-4223>
17. Vial, E., Sahai, E., Marshall, C. J. (2003) ERK-MAPK signaling coordinately regulates activity of Rac1 and RhoA for tumor cell motility. Cancer Cell 4, 67-79. <https://doi.org/10.1016/S1535-6108(03)00162-4>
18. Yazdani, U., Terman, J. R. (2006) The semaphorins. Genome Biol. 7, 211. <https://doi.org/10.1186/gb-2006-7-3-211>
front cover

ISSN 0015-5500 (Print) ISSN 2533-7602 (Online)

Open access journal

Submissions

Archive